U.S. Water Utilities Stock News

NYSE:JNJ
NYSE:JNJPharmaceuticals

Is Johnson & Johnson (JNJ) Still Attractive After A 55% One Year Share Price Gain

If you are wondering whether Johnson & Johnson shares still offer value at around US$218.01, you are not alone. Many investors are asking the same question as the stock sits near its recent levels. The stock has been relatively steady over the last week with a 0.2% decline, while the 30 day return of 5.2% and 1 year return of 54.7% put recent performance in clear focus. Recent headlines around Johnson & Johnson continue to focus on its position as a large healthcare company, including...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

Why TG Therapeutics (TGTX) Is Up 6.9% After Issuing 2026 BRIUMVI-Centric Revenue Guidance And What's Next

TG Therapeutics recently reported preliminary results indicating BRIUMVI U.S. net product revenue of about US$182 million for the fourth quarter of 2025 and approximately US$594 million for the full year, contributing to an estimated US$616 million in total global 2025 revenue. The company also issued 2026 guidance targeting about US$875–900 million in global revenue, with BRIUMVI U.S. net product revenue expected to account for roughly US$825–850 million, underscoring how central this...
NYSE:DBRG
NYSE:DBRGCapital Markets

Is It Too Late To Consider DigitalBridge Group (DBRG) After Its Recent Share Price Surge

If you are wondering whether DigitalBridge Group is priced attractively or starting to look stretched, the recent share performance gives you some useful clues before we talk numbers. The stock last closed at US$15.34, with a 17.7% gain over 30 days, a 34.3% return over the past year, a 19.2% return over three years, and a 12.5% decline over five years, while year to date it is roughly flat with a 0.3% decline. Recent news around DigitalBridge Group has focused on its position as a...
NYSE:MMM
NYSE:MMMIndustrials

Assessing 3M (MMM) Valuation After Recent Share Price Weakness And Conflicting P/E And DCF Signals

How 3M’s recent performance frames the stock today 3M (MMM) has been relatively weak in the short term, with a 1 day return of about a 0.2% decline and a 7 day return of roughly an 8.3% decline, setting the context for recent trading sentiment. See our latest analysis for 3M. Looking past this recent weakness, the share price is around $155.88 and the stock combines a softer 90 day share price return of 9.16% decline with a positive 1 year total shareholder return of 6.51%. This may hint at...